Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJectTM Dataset
· medicus pharma ltd
AI Briefing
- 73% clinical clearance in 200-μg cohort at Day 57.
- Medicus Pharma provided a positive Phase 2 dataset interpretation.
- The 200-μg cohort showed promising results.
Advertisement